Generate Named to 2022 Forbes AI 50 List

Forbes Mag­a­zine has named Generate:Biomedicines to the fourth annu­al Forbes AI 50 List, which rec­og­nizes stand­outs in pri­vate­ly-held North Amer­i­can com­pa­nies mak­ing the most inter­est­ing and effec­tive use of arti­fi­cial intel­li­gence tech­nol­o­gy. Gen­er­ate is one of only five phar­ma­ceu­ti­cal com­pa­nies named to the list. Forbes com­piles an annu­al list to spot­light the most promis­ing star­tups that are emerg­ing as lead­ers in this space.

The Forbes AI 50 list was compiled through a submission process open to any company developing technology that enables machines to learn from experience or new data or perform human-like tasks such as recognizing speech or images, classifying information, and predicting outcomes.